Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Assets (2020 - 2025)

Cellebrite DI (CLBT) has 5 years of Assets data on record, last reported at $938.9 million in Q4 2025.

  • For Q4 2025, Assets rose 35.95% year-over-year to $938.9 million; the TTM value through Dec 2025 reached $938.9 million, up 35.95%, while the annual FY2025 figure was $938.9 million, 35.95% up from the prior year.
  • Assets reached $938.9 million in Q4 2025 per CLBT's latest filing, up from $690.6 million in the prior quarter.
  • Across five years, Assets topped out at $938.9 million in Q4 2025 and bottomed at $339.8 million in Q4 2021.
  • Average Assets over 5 years is $581.1 million, with a median of $532.9 million recorded in 2023.
  • Peak YoY movement for Assets: increased 18.69% in 2022, then soared 35.95% in 2025.
  • A 5-year view of Assets shows it stood at $339.8 million in 2021, then rose by 18.69% to $403.3 million in 2022, then soared by 32.13% to $532.9 million in 2023, then rose by 29.59% to $690.6 million in 2024, then skyrocketed by 35.95% to $938.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $938.9 million in Q4 2025, $690.6 million in Q4 2024, and $532.9 million in Q4 2023.